Remdesivir versus Standard of Care in Moderate to Severe COVID-19 Patients: A Retrospective Study

Introduction: In December 2019, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a novel coronavirus, was first identified as the cause of a respiratory illness designated Coronavirus Disease 2019 (COVID-19). Since then, several antiviral drugs have been evaluated for the treatment o...

Full description

Bibliographic Details
Main Authors: JM JEETENDRA KUMAR, SB VAIBHAV, HR AVINASH, P PRATHEEK
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2021-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/14767/48386_CE[Ra1]_F[SK]_PF1(AG_SL)_PFA(KM)_PB(AG_KM)_PN(KM).pdf